Innate immune activation in neurodegenerative disease
The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.
Abstract
The triggering of innate immune mechanisms is emerging as a crucial component of major neurodegenerative diseases. Microglia and other cell types in the brain can be activated in response to misfolded proteins or aberrantly localized nucleic acids. This diverts microglia from their physiological and beneficial functions, and leads to their sustained release of pro-inflammatory mediators. In this Review, we discuss how the activation of innate immune signalling pathways - in particular, the NOD-, LRR- and pyrin domain-containing 3 (NLRP3) inflammasome - by aberrant host proteins may be a common step in the development of diverse neurodegenerative disorders. During chronic activation of microglia, the sustained exposure of neurons to pro-inflammatory mediators can cause neuronal dysfunction and contribute to cell death. As chronic neuroinflammation is observed at relatively early stages of neurodegenerative disease, targeting the mechanisms that drive this process may be useful for diagnostic and therapeutic purposes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is corollary evidence for inflammation in FTD (Heneka et al., 2014), from genetic (Guerreiro et al., 2013; Rayaprolu et al., 2013; Broce et al., 2018), CSF (Sjogren et al., 2004; Woollacott et al., 2018), epidemiology (Miller et al., 2013, 2016), post-mortem (Venneti et al., 2008; Lant et al., 2014) and animal studies (Yoshiyama et al., 2007; Bhaskar et al., 2010; Yin et al., 2010).”
From Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum (2020) · cites this paper as Heneka et al., 2014
In the citing paper
“in AD, the chronic release of DAMPs, mitochondrial-released DAMPs and pro-inflammatory molecules contributes to the onset and progression of neurodegeneration [57, 76, 97, 149, 194, 270, 304, 333, 345]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [149]
In the citing paper
“This is thought to divert microglia from performing house-keeping functions, promoting a low-grade inflammatory state and CNS damage [149, 333]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [149]
In the citing paper
“studies have shown that cellular aging, infection, traumatic brain injury, systemic inflammation, chronic inflammatory diseases, obesity and poor oral health occurring during middle adulthood can lead to increased pro-inflammatory signals in the periphery, which may contribute to glial activation and the onset and/or perpetuation of neurodegeneration [93, 105, 149, 333]”
From Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function (2022) · cites this paper as [149]
In the citing paper
“TLRs and associated signaling pathways contribute to both injurious and regenerative processes in CNS diseases (33–35).”
From UNC93B1 Is Widely Expressed in the Murine CNS and Is Required for Neuroinflammation and Neuronal Injury Induced by MicroRNA let-7b (2021) · cites this paper as [33]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., et al. (2010) · Science · doi:10.1126/science.1194637 · Cited by 5,175
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
ATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Cited by
Items 101–200 of 1,004
β-Amyloid Clustering around ASC Fibrils Boosts Its Toxicity in Microglia
Friker, L. L., Scheiblich, H., Hochheiser, I. V., Brinkschulte, R., Riedel, D., Latz, E., Geyer, M., & Heneka, M. T. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.025 · Cited by 191
“PRR ligation then fuels signaling transduction pathways that induce an inflammatory response and also lead to clearance of debris by phagocytosis (Heneka et al., 2014).”
BackgroundSelf-citationMumaw, C. L., Levesque, S., McGraw, C., Robertson, S., Lucas, S., Stafflinger, J. E., Campen, M. J., Hall, P., Norenberg, J. P., Anderson, T., et al. (2016) · The FASEB Journal · doi:10.1096/fj.201500047 · Cited by 190
“Neuropathology and CNS disease are believed to occur when the microglial proinflammatory response is exacerbatedandunregulated (29, 30),which is linked to microglial priming (31).”
BackgroundAstrocyte and Oligodendrocyte Cross-Talk in the Central Nervous System
Nutma, E., van Gent, D., Amor, S., & Peferoen, L. A. N. (2020) · Cells · doi:10.3390/cells9030600 · Cited by 183
“Abnormalities in iron metabolism are also reported in MS [72] and HD [74] and restoration of normal metabolism is required for remyelination.”
BackgroundThe involvement of NLRP3 inflammasome in the treatment of Alzheimer’s disease
Feng, Y.-S., Tan, Z.-X., Wu, L.-Y., Dong, F., & Zhang, F. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101192 · Cited by 184
Zhang, Z., Zou, X., Zhang, R., Xie, Y., Feng, Z., Li, F., Han, J., Sun, H., Ouyang, Q., Hua, S., et al. (2021) · Aging · doi:10.18632/aging.202466 · Cited by 180
“Microglia, the major central nervous system resident innate immune cells, play an important role in modulating neuroinflammation [11].”
BackgroundFranklin, T. C., Wohleb, E. S., Zhang, Y., Fogaça, M., Hare, B., & Duman, R. S. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.06.034 · Cited by 180
Recent Advances of the NLRP3 Inflammasome in Central Nervous System Disorders
Zhou, K., Shi, L., Wang, Y., Chen, S., & Zhang, J. (2016) · Journal of Immunology Research · doi:10.1155/2016/9238290 · Cited by 178
“It can not only be a consequence but also be a trigger of pathology [105].”
Inflammation, Infectious Triggers, and Parkinson's Disease
Caggiu, E., Arru, G., Hosseini, S., Niegowska, M., Sechi, G., Zarbo, I. R., & Sechi, L. A. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00122 · Cited by 177
“This interplay seems to underlie neuroinflammation which, apart from PD, is a constant feature of numerous neurodegenerative diseases such as Alzheimer’s disease, dementia with Lewy bodies, amyotrophic lateral sclerosis, frontotemporal dementia or Huntington’s disease (6) and may have multiple causes, including defici…”
BackgroundHamelin, L., Lagarde, J., Dorothée, G., Potier, M. C., Corlier, F., Kuhnast, B., Caillé, F., Dubois, B., Fillon, L., Chupin, M., et al. (2018) · Brain · doi:10.1093/brain/awy079 · Cited by 177
Plasmalogens and Chronic Inflammatory Diseases
Bozelli, J. C., Azher, S., & Epand, R. M. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.730829 · Cited by 172
Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration
Sanchez-Mejias, E., Navarro, V., Jimenez, S., Sanchez-Mico, M., Sanchez-Varo, R., Nuñez-Diaz, C., Trujillo-Estrada, L., Davila, J. C., Vizuete, M., Gutierrez, A., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1630-5 · Cited by 175
“Neuroinflammation has been postulated to be a critical factor in the pathogenesis of AD [16, 17, 19].”
BackgroundGao, R., Shi, H., Chang, S., Gao, Y., Li, X., Lv, C., Yang, H., Xiang, H., Yang, J., Xu, L., et al. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.04.022 · Cited by 173
Lindahl, M., Saarma, M., & Lindholm, P. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.009 · Cited by 174
Thomas, J., Thomas, C. J., Radcliffe, J., & Itsiopoulos, C. (2015) · BioMed Research International · doi:10.1155/2015/172801 · Cited by 173
Jang, J., Park, S., Jin Hur, H., Cho, H.-J., Hwang, I., Pyo Kang, Y., Im, I., Lee, H., Lee, E., Yang, W., et al. (2016) · Nature Communications · doi:10.1038/ncomms13129 · Cited by 166
Feng, L., Chen, Y., Ding, R., Fu, Z., Yang, S., Deng, X., & Zeng, J. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0409-2 · Cited by 170
“and NO are released through activated NADPH oxidase and iNOS [17], both of which play pivotal roles in ICHinduced brain damage [15, 16].”
Van Zeller, M., Dias, D., Sebastião, A. M., & Valente, C. A. (2021) · Journal of Alzheimer's Disease · doi:10.3233/jad-210268 · Cited by 169
“However, although microglia and astrocytes have a crucial role as effectors of neuroinflammation, other cells, including neurons, express receptors for cytokines and other inflammatory mediators and can therefore participate in the coordinated inflammatory response within the CNS [25, 26].”
BackgroundHypothalamic innate immune reaction in obesity
Kälin, S., Heppner, F. L., Bechmann, I., Prinz, M., Tschöp, M. H., & Yi, C.-X. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.48 · Cited by 167
Defective mitochondrial fission augments NLRP3 inflammasome activation
Park, S., Won, J.-H., Hwang, I., Hong, S., Lee, H. K., & Yu, J.-W. (2015) · Scientific Reports · doi:10.1038/srep15489 · Cited by 164
Inflammasomes in neurological diseases: emerging pathogenic and therapeutic concepts
Mamik, M. K., & Power, C. (2017) · Brain · doi:10.1093/brain/awx133 · Cited by 161
Salidroside ameliorates Parkinson's disease by inhibiting NLRP3-dependent pyroptosis
Zhang, X., Zhang, Y., Li, R., Zhu, L., Fu, B., & Yan, T. (2020) · Aging · doi:10.18632/aging.103215 · Cited by 163
“NLRP3 inflammasome activation has been confirmed in neurodegenerative diseases, including PD and Alzheimer’s disease (AD) [52, 53].”
BackgroundThe NLRP3 inflammasome triggers sterile neuroinflammation and Alzheimer’s disease
Milner, M. T., Maddugoda, M., Götz, J., Burgener, S. S., & Schroder, K. (2021) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.10.011 · Cited by 161
Roles of NLRP3 inflammasome in intervertebral disc degeneration
Chao-yang, G., Peng, C., & Hai-hong, Z. (2021) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2021.02.204 · Cited by 160
Oligodendroglia and Myelin in Neurodegenerative Diseases: More Than Just Bystanders?
Ettle, B., Schlachetzki, J. C. M., & Winkler, J. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9205-3 · Cited by 160
“For instance, neuroinflammatory processes mediated mainly by astrocytes and microglia are observed in almost all neurodegenerative diseases [6].”
BackgroundRyu, K.-Y., Lee, H.-J., Woo, H., Kang, R.-J., Han, K.-M., Park, H., Lee, S. M., Lee, J.-Y., Jeong, Y. J., Nam, H.-W., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1561-x · Cited by 160
Neuroimmune Connections in Aging and Neurodegenerative Diseases
Scheiblich, H., Trombly, M., Ramirez, A., & Heneka, M. T. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.02.002 · Cited by 166
Self-citationThe Ayurvedic plant Bacopa monnieri inhibits inflammatory pathways in the brain
Nemetchek, M. D., Stierle, A. A., Stierle, D. B., & Lurie, D. I. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.07.073 · Cited by 158
“…cytokines such as Tumor Necrosis Factor alpha (TNF-α) and Interleukin 6 (IL-6), and the M2 phenotype that produces the anti-inflammatory cytokine IL-10 and downregulates the M1 response (Nakagawa and Chiba, 2015; Gonzalez et al., 2014; Ganguly and Brenhouse, 2014; Heneka et al., 2014).”
Salidroside Ameliorates Alzheimer's Disease by Targeting NLRP3 Inflammasome-Mediated Pyroptosis
Cai, Y., Chai, Y., Fu, Y., Wang, Y., Zhang, Y., Zhang, X. Z., Zhu, L., Miao, M., & Yan, T. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.809433 · Cited by 178
“, 2014) leads to the continuous exposure of neurons to pro-inflammatory mediators and results in neuronal dysfunction or death (Heneka et al., 2014).”
BackgroundMAPK signaling determines lysophosphatidic acid (LPA)-induced inflammation in microglia
Plastira, I., Bernhart, E., Joshi, L., Koyani, C. N., Strohmaier, H., Reicher, H., Malle, E., & Sattler, W. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01809-1 · Cited by 155
“Neurodegenerative disorders are characterized by one or more disease-specific mechanism(s) that induce inflammatory responses [6].”
BackgroundLabel-free characterization of white blood cells by measuring 3D refractive index maps
Yoon, J. W., Kim, K., Park, H., Choi, C., Jang, S., & Park, Y. (2015) · Biomedical Optics Express · doi:10.1364/boe.6.003865 · Cited by 152
“With regard to immunology, the characterization of WBCs is important for understanding the pathophysiology of many diseases, including autoimmune diseases [2], neurodegenerative diseases [3], and cancer [4].”
BackgroundSTAT1 drives M1 microglia activation and neuroinflammation under hypoxia
Butturini, E., Boriero, D., Carcereri de Prati, A., & Mariotto, S. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.05.011 · Cited by 154
Microglia inflict delayed brain injury after subarachnoid hemorrhage
Schneider, U. C., Davids, A., Brandenburg, S., Mueller, A., Elke, A., Magrini, S., Atangana, E. N., Turkowski, K., Finger, T., Gutenberg, A., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1440-1 · Cited by 167
“At the same time, as described for other CNS diseases, prolonged and sustained activation of microglia may result in a negative-feedback loop ultimately resulting in an overshoot-type of microglial reaction similarly as described in animal models of Alzheimer’s disease, where prolonged innate immune activation includi…”
ResultMicroglial dysfunction connects depression and Alzheimer’s disease
Santos, L. E., Beckman, D., & Ferreira, S. T. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.11.011 · Cited by 154
“…and subsequent proliferation in many pathological contexts has been studied extensively in the past decades, and is discussed in a number of excellent recent reviews (e.g.: Heneka et al., 2014; Hu et al., 2014; Lynch, 2014; Perry and Holmes, 2014; Von Bernhardi et al., 2010; Yirmiya et al., 2015).”
BackgroundBiomarkers used in Alzheimer’s disease diagnosis, treatment, and prevention
Mahaman, Y. A. R., Embaye, K. S., Huang, F., Li, L., Zhu, F., Wang, J.-Z., Liu, R., Feng, J., & Wang, X. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101544 · Cited by 149
Liu, X., Hao, W., Qin, Y., Decker, Y., Wang, X., Burkart, M., Schötz, K., Menger, M. D., Fassbender, K., & Liu, Y. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.01.011 · Cited by 149
Activation of the NLRP 3 inflammasome in microglia: the role of ceramide
Scheiblich, H., Schlütter, A., Golenbock, D. T., Latz, E., Martinez‐Martinez, P., & Heneka, M. T. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14225 · Cited by 147
Self-citationMicroglial inflammation and phagocytosis in Alzheimer's disease: Potential therapeutic targets
Nizami, S., Hall‐Roberts, H., Warrier, S., Cowley, S. A., & Di Daniel, E. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14618 · Cited by 147
Immunosenescence: signaling pathways, diseases and therapeutic targets
Fu, Y., Wang, B., Alu, A., Hong, W., Hong, L., He, X., Shi, H., Cheng, P., & Yang, X. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02371-z · Cited by 187
“162 Additionally, the meningeal lymphatic system is crucial for A β clearance, and its function is impaired with age, leading to cognitive decline.”
Microglia Participate in Neurogenic Regulation of Hypertension
Shen, X. Z., Li, Y., Li, L., Shah, K. H., Bernstein, K. E., Lyden, P., & Shi, P. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05333 · Cited by 146
“On stimulation, microglia promptly undergo a series of morphological and phenotypic changes, eventually releasing mediators that can directly modulate neuronal activities.(13,14) Moreover, many lines of evidence indicate that microglia are highly involved in shaping neuronal behavior via sculpting dendritic spine form…”
BackgroundNeuroinflammatory responses in Alzheimer’s disease
Dansokho, C., & Heneka, M. T. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1831-7 · Cited by 158
Self-citationAn Integrative Approach to Neuroinflammation in Psychiatric disorders and Neuropathic Pain
Lurie, D. I. (2018) · Journal of Experimental Neuroscience · doi:10.1177/1179069518793639 · Cited by 154
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
Henjum, K., Almdahl, I. S., Årskog, V., Minthon, L., Hansson, O., Fladby, T., & Nilsson, L. N. G. (2016) · Alzheimer's Research & Therapy · doi:10.1186/s13195-016-0182-1 · Cited by 143
“Aging is associated with gliosis, increased microglial activity [5] and astrocytosis in the brain [34].”
BackgroundNLRP3 inflammasome in ischemic stroke: As possible therapeutic target
Alishahi, M., Farzaneh, M., Ghaedrahmati, F., Nejabatdoust, A., Sarkaki, A., & Khoshnam, S. E. (2019) · International Journal of Stroke · doi:10.1177/1747493019841242 · Cited by 153
Morroni, F., Sita, G., Graziosi, A., Turrini, E., Fimognari, C., Tarozzi, A., & Hrelia, P. (2018) · Aging and disease · doi:10.14336/ad.2017.0903 · Cited by 140
“AβO activate microglia, which causes inflammation in the brain and promotes the production of cytokines and other inflammatory mediators that might contribute to dysfunction, injury, and ultimately neuronal loss [74].”
BackgroundRusek, M., Smith, J., El-Khatib, K., Aikins, K., Czuczwar, S. J., & Pluta, R. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010864 · Cited by 154
“Moreover, TREM2 regulates the phagocytic process and the removal of neuronal debris and amyloid deposits [45,53].”
BackgroundMicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson’s disease by targeting Nlrp3
Li, D., Yang, H., Ma, J., Luo, S., Chen, S., & Gu, Q. (2018) · Human Cell · doi:10.1007/s13577-017-0187-5 · Cited by 140
“Sustained aberrant expression levels of several different miRs have been described in inflammation-related neurodegenerative disorders, including multiple sclerosis (MS), AD, ALS and PD [15–18].”
BackgroundUSP5 attenuates NLRP3 inflammasome activation by promoting autophagic degradation of NLRP3
Cai, B., Zhao, J., Zhang, Y., Liu, Y., Ma, C., Yi, F., Zheng, Y., Zhang, L., Chen, T., Liu, H., et al. (2021) · Autophagy · doi:10.1080/15548627.2021.1965426 · Cited by 148
Melo, H. M., Seixas da Silva, G. D. S., Sant’Ana, M. R., Teixeira, C. V. L., Clarke, J. R., Miya Coreixas, V. S., de Melo, B. C., Fortuna, J. T. S., Forny-Germano, L., Ledo, J. H., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.072 · Cited by 140
Ledo, J. H., Azevedo, E. P., Beckman, D., Ribeiro, F. C., Santos, L. E., Razolli, D. S., Kincheski, G. C., Melo, H. M., Bellio, M., Teixeira, A. L., et al. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.1269-16.2016 · Cited by 138
“Chronic inflammation becomes deleterious and leads to progressive brain damage and neurodegeneration (Wyss-Coray and Mucke, 2002; Heneka et al., 2014, 2015), playing a critical role in the pathogenesis of AD.”
InfluentialFunctional and structural damage of neurons by innate immune mechanisms during neurodegeneration
Ising, C., & Heneka, M. T. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0153-x · Cited by 128
Self-citationAn epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer’s disease
Ghosh, A., Comerota, M. M., Wan, D., Chen, F., Propson, N. E., Hwang, S. H., Hammock, B. D., & Zheng, H. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abb1206 · Cited by 136
Microglia in Alzheimer's Disease: Risk Factors and Inflammation
Katsumoto, A., Takeuchi, H., Takahashi, K., & Tanaka, F. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00978 · Cited by 136
“, ATP, reactive oxygen species, damaged mitochondria, and necrotic cells) activate microglia and resident mononuclear phagocytes in the CNS, which promote neuroprotection and repair through the clearance of tissue debris and subsequent resolution of the inflammatory response (28, 29).”
BackgroundEmerging roles of extracellular vesicles in neurodegenerative disorders
You, Y., & Ikezu, T. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104512 · Cited by 136
“These aggregates would cause toxicity in cells and involve multiple mechanisms including neuronal death [119], synaptic dysfunction [120], and immune activation [121].”
BackgroundBellaver, B., Souza, D. G., Souza, D. O., & Quincozes-Santos, A. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-9880-8 · Cited by 135
Inflammatory aspects of Alzheimer’s disease
Lucena, P. B., & Heneka, M. T. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02790-2 · Cited by 166
“…activation of microglia and astrocytes, neuroinflammation has garnered attention in recent years due to the early presence in the disease course, even before histopathological and pathological features of degeneration can be detected, representing an attractive therapeutic approach [92, 93, 257].”
Self-citationMicroglial Malfunction: The Third Rail in the Development of Alzheimer's Disease
Mhatre, S. D., Tsai, C. A., Rubin, A. J., James, M. L., & Andreasson, K. I. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.08.006 · Cited by 134
“Extensive data in mouse AD models demonstrates that, similarly to tau, oligomeric and fibrillar Ab peptides also elicit a vigorous microglial innate immune response (reviewed in [91]).”
The Immune System and the Role of Inflammation in Perinatal Depression
Leff, P., Mancilla‐Herrera, I., Flores‐Ramos, M., Cruz-Fuentes, C. S., Reyes‐Grajeda, J. P., García-Cuétara, M. D. P., Bugnot-Pérez, M. D., & Pulido-Ascencio, D. E. (2016) · Neuroscience Bulletin · doi:10.1007/s12264-016-0048-3 · Cited by 139
“TLR4 has recently been implicated in several neuropathological conditions of the CNS, for instance, neuropathic pain [135] and neurodegenerative disorders [136].”
BackgroundInnate Immune Response in Brain, NF-Kappa B Signaling and Cystatins
Kopitar‐Jerala, N. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00073 · Cited by 147
“Recently, several reviews described the role of innate immune response and inflammasome activation in neurodegenerative diseases (Heneka et al., 2014, 2015; Freeman and Ting, 2015).”
BackgroundCB2 Cannabinoid Receptor As Potential Target against Alzheimer's Disease
Aso, E., & Ferrer, I. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00243 · Cited by 156
“Activated microglia produce cytokines and mediators of inflammatory response which, in combination with neurons and astrocytes, create a complex cytokine cycle with deleterious consequences in brain when sustained over time (Heneka et al., 2014; McGeer and McGeer, 2015).”
BackgroundSoluble α-synuclein–antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia
Trudler, D., Nazor, K. L., Eisele, Y. S., Grabauskas, T., Dolatabadi, N., Parker, J., Sultan, A., Zhong, Z., Goodwin, M. S., Levites, Y., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025847118 · Cited by 131
Tedaldi, E., Minniti, N. L., & Fischer, T. (2015) · BioMed Research International · doi:10.1155/2015/641913 · Cited by 153
“Communication pathways from the periphery to the brain are well reviewed [192–194] and involve cytokines commonly seen in systemic infections and inflammatory conditions, including interleukin-(IL-) 1 𝛽 , IL-6, and tumor necrosis alpha (TNF 𝛼 ), which are also elevated in HIV infection.”
The Future of Precision Medicine in the Cure of Alzheimer’s Disease
Arafah, A., Khatoon, S., Rasool, I., Khan, A., Rather, M. A., Abujabal, K. A., Faqih, Y. A. H., Rashid, H., Rashid, S. M., Bilal Ahmad, S., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11020335 · Cited by 133
Macrophage activation in human diseases
Schultze, J. L., Schmieder, A., & Goerdt, S. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.07.003 · Cited by 147
Inflammasomes as therapeutic targets for Alzheimer's disease
White, C. S., Lawrence, C. B., Brough, D., & Rivers‐Auty, J. (2017) · Brain Pathology · doi:10.1111/bpa.12478 · Cited by 130
“The most extensively studied inflammasome is the NLRP3 inflammasome and has been strongly implicated in AD pathology (57).”
BackgroundGao, J., Zhou, R., You, X., Luo, F., He, H., Chang, X., Zhu, L., Ding, X., & Yan, T. (2016) · Metabolic Brain Disease · doi:10.1007/s11011-016-9813-2 · Cited by 130
α‐Synuclein evokes NLRP3 inflammasome‐mediated IL‐1β secretion from primary human microglia
Pike, A. F., Varanita, T., Herrebout, M. A. C., Plug, B. C., Kole, J., Musters, R. J. P., Teunissen, C. E., Hoozemans, J. J. M., Bubacco, L., & Veerhuis, R. (2021) · Glia · doi:10.1002/glia.23970 · Cited by 126
“…(2) the small adaptor molecule known as apoptosis-associated speck-like protein containing a caspase activation and recruitment domain (CARD), or ASC, and (3) the cysteine-aspartate protease-1 (caspase-1) (Boucher et al., 2018; Heneka et al., 2014; Latz et al., 2013; Schroder & Tschopp, 2010).”
BackgroundWang, H., Yang, F., Zhang, S., Xin, R., & Sun, Y. (2021) · npj Parkinson's Disease · doi:10.1038/s41531-021-00213-7 · Cited by 126
Microglia in Aging and Alzheimer’s Disease: A Comparative Species Review
Edler, M. K., Mhatre-Winters, I., & Richardson, J. R. (2021) · Cells · doi:10.3390/cells10051138 · Cited by 126
“In addition, evidence indicates that chronic neuroinflammation, mediated by microglia, may play a role in the pathogenesis of AD [19].”
BackgroundTargeting innate immunity for neurodegenerative disorders of the central nervous system
Andreasson, K. I., Bachstetter, A. D., Colonna, M., Ginhoux, F., Holmes, C., Lamb, B., Landreth, G., Lee, D. C., Low, D., Lynch, M. A., et al. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13667 · Cited by 126
Microglial Phenotypes and Functions in Multiple Sclerosis
O’Loughlin, E., Madore, C., Lassmann, H., & Butovsky, O. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a028993 · Cited by 124
“Activated amoeboid microglia can induce detrimental cellular damage to the host by releasing anumberof inflammatory mediators, including proinflammatory cytokines, ROS, RNI, and various complement proteins (Mayo et al. 2012; Gonzalez et al. 2014; Heneka et al. 2014).”
BackgroundYao, Y., Vent-Schmidt, J., McGeough, M. D., Wong, M., Hoffman, H. M., Steiner, T. S., & Levings, M. K. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403225 · Cited by 125
López-González, I., Schlüter, A., Aso, E., Garcia-Esparcia, P., Ansoleaga, B., LLorens, F., Carmona, M., Moreno, J., Fuso, A., Portero-Otin, M., et al. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000176 · Cited by 125
“The CNS is not an exception to this process, as innate immune cells in the brain 2015 American Association of Neuropathologists, Inc.336 Copyright © 2015 by the American Association of Neuropathologists, Inc. Unauthorized reproduction of this article is prohibited. become more reactive with aging (67).”
BackgroundDiversity of astroglial responses across human neurodegenerative disorders and brain aging
Ferrer, I. (2017) · Brain Pathology · doi:10.1111/bpa.12538 · Cited by 124
“Astrocytes in neurodegenerative diseases may be a source of reactive oxygen and reactive nitrogen species occurring in parallel with the generation of certain peptides and proteins such as b-amyloid, superoxide dismutase 1 (SOD1), TAR DNA-binding protein 43 (TDP-43) and prion protein scrapie (PrP) (4, 9, 78, 133, 176,…”
BackgroundBéland, L.-C., Markovinovic, A., Jakovac, H., De Marchi, F., Bilic, E., Mazzini, L., Kriz, J., & Munitic, I. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa124 · Cited by 125
“Numerous other damage sensors might be important for microglial activation in neurodegenerative diseases including complement receptors, P2 purinergic receptors (for ATP), receptors for advanced glycation end products (RAGE), inflammasomes and triggering receptor expressed on myeloid cells 2 (TREM2) (Davalos et al., 2…”
BackgroundInfluentialNeuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum
Bevan-Jones, W. R., Cope, T. E., Jones, P. S., Kaalund, S. S., Passamonti, L., Allinson, K., Green, O., Hong, Y. T., Fryer, T. D., Arnold, R., et al. (2020) · Brain · doi:10.1093/brain/awaa033 · Cited by 124
Clark, I. A., & Vissel, B. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0708-2 · Cited by 123
“Refinements of these scientific arguments have accumulated to the present day [35–41].”
BackgroundLipoprotein lipase maintains microglial innate immunity in obesity.
Gao, Y., Vidal-Itriago, A., Kalsbeek, M. J., Layritz, C., García-Cáceres, C., Tom, R. Z., Eichmann, T. O., Vaz, F. M., Houtkooper, R. H., van der Wel, N., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.008 · Cited by 123
“In neurodegenerative disease, reactive microglia associated with inflammatory agents are considered amajor cause of nearby neuronal death (Heneka et al., 2014).”
Aguzzi, A., & Zhu, C. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90605 · Cited by 122
“Microglial activation represents one of the hallmarks of many neurodegenerative diseases (20).”
Microglial priming in Alzheimer’s disease
Li, J.-W., Zong, Y., Cao, X.-P., Tan, L., & Tan, L. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.04.22 · Cited by 122
“peptides or mislocalized nucleic acids have been identified as the misfolded proteins via a series of pathways named danger-associated molecular patterns (DAMPs) (33).”
BackgroundScheiblich, H., Bousset, L., Schwartz, S., Griep, A., Latz, E., Melki, R., & Heneka, M. T. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100035 · Cited by 122
“On ligation of pattern recognition receptors (PRRs),microglia become activated and execute an inflammatory response that, if it persists, causes chronic neuroinflammation and neuronal damage (13, 14).”
BackgroundSelf-citationAlfonso‐Loeches, S., Ureña‐Peralta, J. R., Morillo-Bargues, M. J., Gómez‐Pinedo, U., & Guerri, C. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1760-5 · Cited by 136
Pike, A. F., Longhena, F., Faustini, G., van Eik, J.-M., Gombert, I., Herrebout, M. A. C., Fayed, M. M. H. E., Sandre, M., Varanita, T., Teunissen, C. E., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02410-4 · Cited by 145
“Another characteristic contributor to PD pathology is neuroinflammation mediated by pro-inflammatory cytokines such as interleukin-1β (IL-1β) that are secreted mainly by activated microglia [9, 10].”
BackgroundLammerding, L., Slowik, A., Johann, S., Beyer, C., & Zendedel, A. (2016) · Neuroendocrinology · doi:10.1159/000439435 · Cited by 120
Cheng, Y., Song, Y., Chen, H., Li, Q., Gao, Y. Z., Lu, G., & Luo, C. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5005136 · Cited by 129
“Capillary endothelial cells and permeable blood cells also participate in neuroinflammation, especially when the blood-brain barrier (BBB) is subjected to biochemical or mechanical damage [86, 87].”
BackgroundLiu, J., Buisman-Pijlman, F., & Hutchinson, M. R. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00309 · Cited by 119
“Yet, current treatments targeting serotonergic and noradrenaline reuptake systems are insufficient to provide long-term relief from depressive symptoms in most patients, indicating the need for new treatment targets.”
BackgroundUllah, F., Liang, A., Rangel, A., Gyengési, E., Niedermayer, G., & Münch, G. W. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-1939-4 · Cited by 125
Role of Immunity and Inflammation in the Pathophysiology of Neurodegenerative Diseases
Fakhoury, M. (2015) · Neurodegenerative Diseases · doi:10.1159/000369933 · Cited by 118
Unger, M. S., Schernthaner, P., Marschallinger, J., Mrowetz, H., & Aigner, L. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1304-4 · Cited by 118
PRECISION MEDICINE - THE GOLDEN GATE FOR DETECTION, TREATMENT AND PREVENTION OF ALZHEIMER’S DISEASE
Hampel, H., O’Bryant, S. E., Castrillo, J. I., Ritchie, C., Rojkova, K., Broich, K., Benda, N., Nisticò, R., Frank, R. A., Dubois, B., et al. (2016) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2016.112 · Cited by 115
“Therefore, profiling biological pathways associated with AD may highlight novel opportunities for therapeutics (88, 89); notably, inflammatory pathways may represent such targets (90, 91).”
Decreased salivary lactoferrin levels are specific to Alzheimer's disease
González‐Sánchez, M., Bartolomé, F. B., Antequera, D., Puertas‐Martín, V., González, P., Gómez‐Grande, A., Velasco, S. L., Martín, A. H. S., Pérez-Martínez, D. A., Villarejo‐Galende, A., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102834 · Cited by 122
He, X., Li, L., Xian, W., Li, M., Zhang, L., Xu, J., Pei, Z., Zheng, H., & Hu, X. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02199-8 · Cited by 128
“Neuroin ammation is strongly implicated in the pathogenesis of age-related cognitive decline, including that associated with Alzheimer’s disease (AD), the most common form of dementia in older adults [1].”
BackgroundAstroglia and Tau: New Perspectives
Kovacs, G. G. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00096 · Cited by 115
Depletion of microglia augments the dopaminergic neurotoxicity of MPTP
Yang, X., Ren, H., Wood, K., Li, M., Qiu, S., Shi, F.-D., Ma, C., & Liu, Q. (2018) · The FASEB Journal · doi:10.1096/fj.201700833rr · Cited by 115
Targeting NLRP3 Inflammasome Activation in Severe Asthma
Theofani, E., Semitekolou, M., Morianos, I., Samitas, Κ., & Xanthou, G. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101615 · Cited by 127
Pharmacological approaches to mitigate neuroinflammation in Alzheimer’s disease
Uddin, M. S., Kabir, M. T., Mamun, A. A., Barreto, G. E., Rashid, M., Perveen, A., & Ashraf, G. M. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106479 · Cited by 114
The role of the immune system in Alzheimer’s disease
Wu, K., Zhang, Y.-R., Huang, Y., Dong, Q., Tan, L., & Yu, J. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101409 · Cited by 127
Baldacci, F., Lista, S., Cavedo, E., Bonuccelli, U., & Hampel, H. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1304217 · Cited by 113
“An increased production of proinflammatory cytokines has been reported in clinical cohorts of PD, ALS, and HD patients [10,11].”
BackgroundThe Mechanism of Acrylamide-Induced Neurotoxicity: Current Status and Future Perspectives
Zhao, M., Zhang, B., & Deng, L. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.859189 · Cited by 135
Peixoto, C. A., Nunes, A. K. S., & García‐Osta, A. (2015) · Mediators of Inflammation · doi:10.1155/2015/940207 · Cited by 120
“NLRP3 inflammasome activation has been described in several neurodegenerative diseases such as AD and amyotrophic lateral sclerosis (for review, see Heneka et al., 2014) [56].”
BackgroundMethodShao, S., Xu, C.-B., Chen, C.-J., Shi, G.-N., Guo, Q.-L., Zhou, Y., Wei, Y.-Z., Wu, L., Shi, J.-G., & Zhang, T.-T. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02178-z · Cited by 112
“PAMPs activate the priming signal of NLRP3 inflammasome, and DAMPs act as the second signal that promote neuroinflammation and facilitate transmission of pain signals from the primary center to the superior center [11, 14, 20, 21].”
Background
Metadata
- Authors
- Heneka, M. T., Kummer, M. P., & Latz, E.
- Affiliations
- University of Bonn (DE)
- Corresponding author
- Heneka, Michael T.
- Venue
- Nature Reviews Immunology
- Published
- 2014-06-25
- Volume
- 14
- Issue
- 7
- Pages
- 463-477
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1986611577
- Cited by
- 1,437
- References
- 171
- Citations by year
- 2026: 109 · 2025: 137 · 2024: 118 · 2023: 104 · 2022: 125 · 2021: 143 · 2020: 158 · 2019: 117 · 2018: 116 · 2017: 106 · 2016: 96 · 2015: 97 · 2014: 9
- FWCI
- 8.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion)
- DZNE Pub (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- innate immunity, neurodegenerative diseases, neuroinflammation, microglia, NLRP3 inflammasome, NOD-like receptors, misfolded proteins, pro-inflammatory mediators, neuronal dysfunction, neuronal cell death, neurodegeneration therapy
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Brain, Carrier Proteins, Humans, Immunity, Innate, Inflammation, Signal Transduction, Cytokines, Amyloid beta-Peptides, Reactive Oxygen Species, Protein Folding, Microglia, Oxidative Stress, Neurodegenerative Diseases, Reactive Nitrogen Species, Receptors, Pattern Recognition, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.